PMID: 9176543May 1, 1997Paper

Anti-interleukin 5 strategies as a potential treatment for asthma

Thorax
A D Singh, C J Sanderson

Abstract

A paradigm shift, championed largely by cellular immunologists, has redefined asthma as an immune mediated phenomenon characterised by an interleukin 5 (IL-5) driven eosinophilic bronchitis. This change in emphasis has provoked intense interest in the possibility that inhibitors of IL-5 production, or antagonists of its activity, will provide a new generation of anti-asthma drugs.

References

Nov 1, 1990·The Journal of Experimental Medicine·L A DentC J Sanderson
Apr 1, 1988·The Journal of Antimicrobial Chemotherapy·A J Davies, D S Kumaratne
May 1, 1995·International Archives of Allergy and Immunology·R W EganM W Bodmer
Apr 1, 1993·Respiratory Medicine·C J Trigg, R J Davies
Apr 1, 1996·Immunology and Cell Biology·S KarlenC J Sanderson

❮ Previous
Next ❯

Citations

Mar 20, 2002·Current Allergy and Asthma Reports·T T Hansel, P J Barnes
Dec 22, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J C In 't VeenE H Bel
Jul 11, 1998·Thorax·D F Rogers, G J Laurent
Jan 28, 1999·American Journal of Respiratory Cell and Molecular Biology·C G GarlisiR W Egan
Aug 25, 2009·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Sabina Antonela Antoniu
Nov 4, 2000·Expert Opinion on Investigational Drugs·S A BryanP J Barnes
Jan 4, 2013·Expert Opinion on Biological Therapy·Sabina Antonela Antoniu
Jul 25, 2000·Clinics in Chest Medicine·C Ober, M F Moffatt
Jun 22, 1999·Pulmonary Pharmacology & Therapeutics·C G Garlisi
Jan 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Esther LópezCarlos Lahoz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
P J Barnes
Pulmonary Pharmacology & Therapeutics
J BousquetP Godard
© 2021 Meta ULC. All rights reserved